Listed chronologically, most recent first. Please note: “TRFT” is referred to as “TEMT” in these publications; the labeling change to “TRFT” was recently adopted for increased clarity.

Click on individual publications for a PDF of that publication to appear.

1. Baranowski, R., Amschler, J., Wittwer, D., and G. Arendash. Human Memory Enhancement by Transcranial Radiofrequency Wave Treatment Occurs Without Appreciably Increasing Brain Temperature. Submitted for Publication (2024).
2. Arendash, G., Lin, X., and Cao, C. Enhanced Brain Clearance of Tau and A-beta by Transcranial Radiofrequency Wave Treatment: A Central Role of VEGF. Journal of Alzheimer’s Disease 100100:S223-S241 (2024).
3. Arendash, G., and C. Cao, Transcranial Electromagnetic Wave Treatment: A Fountain of Healthy Longevity? International J. of Molecular Sciences 24: 9652 (2023).
4. Arendash, G., Abulaban, H., Steen, S., Andel, R., Wang, Y., Bai, Y., Baranowski, R., McGarity, J., Scritsmier, L., Lin, X., Shen, N., Aljassabi, A., Li, Y., and C. Cao, Transcranial Electromagnetic Treatment Stops Alzheimer’s Disease Cognitive Decline Over a 2½ Year Period: A Pilot Study. Medicines, Vol. 9, August 3 (2022).
5. Cao, C., Abulaban, H., Baranowski, R., Wang, Y., Bai, I., Lin, X., Shen, N., Zhang, X., and G. Arendash. Transcranial Electromagnetic Treatment “Rebalances” Blood and Brain Cytokine Levels in Alzheimer’s Patients: A New Mechanism for Reversal of Their Cognitive Impairment. Frontiers in Aging Neuroscience: 14, Article 829049 (2022).
6. Arendash, G., Cao, C., Abulaban, H., Baranowski, R., Wisniewski, G., Becerra, L., Andel, R., Lin, X., Zhang X., Wittwer, D., Moulton, J., Arrington, J., and A. Smith. A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer’s Disease: Cognitive Enhancement and Associated Changes in CSF, Blood, and Brain Imaging. Journal of Alzheimer’s Disease Vol 71: 57-82 (2019).
7. Arendash, G. Review of the Evidence that Transcranial Electromagnetic Treatment (TEMT) will be Safe and Effective Against Alzheimer’s Disease. Journal of Alzheimer’s Disease 53: 753-71 (2016).
8. Arendash, G., Mori, T., Dorsey, M., Gonzalez, R., Tajiri, N., and C. Borlongan. Long-Term 918 MHz Electromagnetic Field Treatment to Very Old Alzheimer’s Mice Reverses β-Amyloid Deposition, Modifies Regional Cerebral Blood Flow, & Provides Selected Cognitive Enhancement without Brain Hyperthermia. PLoS ONE Volume 7/Issue4: e35751 (2012).
9. Arendash, G. Transcranial Electromagnetic treatment (TEMT) for Alzheimer’s Disease: Why it has the potential to trump Alzheimer’s drug development. Journal of Alzheimer’s Disease 32:243-266 (2012).
10. Mori, T. and G. Arendash. Electromagnetic field treatment enhances neuronal activity: Linkage to cognitive benefit and therapeutic implications for Alzheimer’s Disease. Journal of Alzheimer’s Disease and Parkinsonism Vol. 1:102 (2011).
11. Dragicevic, N., Bradshaw, P.C., Mamcarz, M., Lin, X., Wang, L., Cao, C., and G. Arendash. Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer’s transgenic mice and normal mice: A mechanism for electromagnetic field-induced cognitive benefit? Neuroscience 185: 135-149 (2011).
12. Arendash, G., Sanchez-Ramos. J., Mori, T., Mamcarz, M., Lin, X., Runfeldt, M., Wang, L., Zhang, G., Sava, V., Jun Tan, J., and C. Cao. Electromagnetic Field Treatment Protects Against and Reverses Cognitive Impairment in Alzheimer’s Mice. Journal of Alzheimer’s Disease 19: 191-210 (2010).